Arlington Trust’s Novartis NVS Stock Holding History

Arlington Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.1K	Hold	288	–	–	﹤0.01%	285
2026 Q1	$44K	Buy	288 +109	+61%	+$16.7K	﹤0.01%	235
2025 Q4	$24.7K	Buy	+179	New	+$23.4K	﹤0.01%	241
2025 Q3	–	Sell	-5	Closed	-$605	–	658
2025 Q2	$605	Buy	+5	New	+$564	﹤0.01%	629
2024 Q1	–	Sell	-20	Closed	-$2.02K	–	763
2023 Q4	$2.02K	Sell	20 -29,006	-100%	-$2.8M	﹤0.01%	630
2023 Q3	$2.96M	Buy	+29,026	New	+$2.95M	1.21%	16

Other funds holding NVS

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

Godsey & Gibb Inc Richmond, Virginia $1.22B AUM 27.93% 1-Year Est. Return

Matthew Goff Investment Advisor Houston, Texas $593M AUM 28.9% 1-Year Est. Return

Eldred Rock Partners San Antonio, Texas $465M AUM 48.86% 1-Year Est. Return

Cohen Capital Management Corte Madera, California $735M AUM 36.88% 1-Year Est. Return

Franklin, Parlapiano, Turner & Welch Houston, Texas $442M AUM 14.73% 1-Year Est. Return

Cullen Investment Group Lafayette, Louisiana $827M AUM 29.64% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.6B AUM 18.11% 1-Year Est. Return

Henry James International Management New York $334M AUM 49.44% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return